1. Home
  2. ST vs PTCT Comparison

ST vs PTCT Comparison

Compare ST & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensata Technologies Holding plc

ST

Sensata Technologies Holding plc

HOLD

Current Price

$49.55

Market Cap

6.1B

Sector

Industrials

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$77.70

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ST
PTCT
Founded
1916
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
5.7B
IPO Year
2009
2006

Fundamental Metrics

Financial Performance
Metric
ST
PTCT
Price
$49.55
$77.70
Analyst Decision
Buy
Buy
Analyst Count
11
17
Target Price
$42.91
$80.65
AVG Volume (30 Days)
2.2M
1.4M
Earning Date
04-28-2026
05-07-2026
Dividend Yield
1.21%
N/A
EPS Growth
N/A
264.48
EPS
0.59
N/A
Revenue
$3,704,500,000.00
$264,734,000.00
Revenue This Year
$6.47
N/A
Revenue Next Year
$4.51
$17.70
P/E Ratio
$85.17
N/A
Revenue Growth
N/A
36.19
52 Week Low
$27.85
$43.18
52 Week High
$53.89
$87.50

Technical Indicators

Market Signals
Indicator
ST
PTCT
Relative Strength Index (RSI) 53.83 62.03
Support Level $33.15 $73.41
Resistance Level $53.89 $79.67
Average True Range (ATR) 2.16 3.10
MACD -0.41 0.54
Stochastic Oscillator 41.87 85.53

Price Performance

Historical Comparison
ST
PTCT

About ST Sensata Technologies Holding plc

Sensata Technologies is a global supplier of sensors and electrical protection for transportation and industrial applications. Sensata sells a bevy of pressure, temperature, force, and position sensors into the automotive, heavy vehicle, industrial, heating, ventilation, and cooling, and aerospace markets. It also sells electrical protection products, like contactors and relays. The majority of the firm's revenue comes from the automotive market, where it focuses on bumper-in applications.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: